Difference between revisions of "Team:UCopenhagen/Interdependency"

Line 136: Line 136:
 
<p class="lead">
 
<p class="lead">
  
We have used <a href="https://static.igem.org/mediawiki/2017/c/cd/GelElectrophoresis_UCopenhagen.pdf">gel electrophoresis</a> across most of our experiments and sub-projects to continually monitor our progress.  
+
We have used <a href="https://static.igem.org/mediawiki/2017/c/cd/GelElectrophoresis_UCopenhagen.pdf">gel electrophoresis</a> in the majority of our experiments and sub-projects to continually monitor the progress.  
  
 
<br><br>
 
<br><br>
Line 144: Line 144:
 
<br><br>
 
<br><br>
  
Subsequently plasmid were <a href="https://static.igem.org/mediawiki/2017/c/c6/Protocol3_UCopenhagen.pdf">cured</a> from the cultures and <a href="https://static.igem.org/mediawiki/2017/2/2e/Protocol1_UCopenhagen.pdf">PCR</a> amplification and/or restriction <a href="https://static.igem.org/mediawiki/2017/a/ab/Protocol13_UCopenhagen.pdf">digestion</a>was used to check for correct insertion. Cells with appropriately sized inserts were sent to <a href="https://static.igem.org/mediawiki/2017/9/9f/Protocol17_UCopenhagen.pdf">sequencing</a> for sequence validation.  
+
Subsequently, plasmids were <a href="https://static.igem.org/mediawiki/2017/c/c6/Protocol3_UCopenhagen.pdf">cured</a> from the cultures and <a href="https://static.igem.org/mediawiki/2017/2/2e/Protocol1_UCopenhagen.pdf">PCR</a> amplification and/or restriction <a href="https://static.igem.org/mediawiki/2017/a/ab/Protocol13_UCopenhagen.pdf">digestion</a> were used to check for correct insertion. Cells with appropriately sized inserts were sent to <a href="https://static.igem.org/mediawiki/2017/9/9f/Protocol17_UCopenhagen.pdf">sequencing</a> for sequence validation.  
 
               </p>
 
               </p>
 +
 +
<h4>Biobrick creation</h4>
 +
 +
<p class="lead">
 +
 +
We amplified our biobricks with primers carrying the biobrick prefixes and suffixes as overhangs, and purified them with gel extraction. Subsequently, we used the standard iGEM protocol for its insertion into the pSB1C3 submission vector. <br><br>
 +
All biobricks were sequenced in the expression vector, and <i>aroG</i>, <i>trpE</i>, CPP and CPP-YFP were also sequenced following their insertion into the submission vector. <br> </p>
 +
 +
<h4>Vector design</h4>
 +
 +
<p class="lead">
 +
 +
A modified version of the <a href="https://www.addgene.org/vector-database/2623/">pET102 vector</a> was used for expression of all genes in this sub-project. See <a href="https://2017.igem.org/Team:UCopenhagen/Protein-Import">protein import</a> for details on design and creation of the vector.<br></p>
 +
 +
<h4>Codon optimization and synthetic <i>yddG</i></h4>
 +
 +
<p class="lead">
 +
 +
Following problems with amplifying <i>yddG</i> from the genomic DNA, we decided to order a synthetically made version, and codon optimized it in the process.<br></p>
 +
 +
<h4>Point mutations for feedback resistance in <i>trpE</i> and <i>aroG</i></h4>
 +
 +
<p class="lead">
 +
 +
We amplified the <i>aroG</i> and <i>trpE</i> genes using genomic DNA from <i>E.coli</i> strain MG1655. The amplification was done using two sets of primers per gene, with overhangs allowing for insertion of a point mutation in each gene and for cloning with USER assembly. <br><br>
 +
 +
The mutations were designed in accordance with previous work by Gu <i>et al</i> 2012. In TrpE, position 293 is changed from methionine to threonine, and for AroG position 150 is changed from proline to leucine. <br><br>
 +
 +
<figure>
 +
<br><br>
 +
<br>
 +
                    <img class="img-responsive" src="https://static.igem.org/mediawiki/2017/5/5d/TrpE_pointmutation.png" alt="" width="250" height="200">
 +
<br>
 +
<figcaption><b>Figure 2 </b>Point mutation in <i>trpE</i>, and insertion in vector with USER assembly. To perform the point mutation, we designed two sets of primers for each gene. The outer primers are the same as used for amplification from the genomic DNA. The central primers have overhangs containing the point mutations.
 +
This way, the genes are split in two, and the two parts are combined when inserting in the USER cassette in the expression vector - and now containing a point mutation in the middle.
 +
</figcaption>
 +
</figure>
 +
</p>
 +
 
     </div>
 
     </div>
 
</div>
 
</div>

Revision as of 12:56, 1 November 2017

I N T E R D E P E N D E N C Y


Introduction

The first mechanism that we have decided to investigate is the interdependency between two cell types. In order to have a stable relationship in which the host-endosymbiont relationship is maintained through generations, the host and endosymbionts must depend on each other for their continued survival.

Within the endosymbiotic relationship, we envision a resource based cross-network between host and symbiont. The exchange of vital metabolites, necessary for proliferation, would ensure the coexistence of the symbiotic pair, whilst also ensuring mutual demise in case of the host’s or the symbiont’s perishment. Our goal would be that the pair would survive only if the condition of endosymbiosis is met.

This is important, as our project is about laying the foundation for stable modular endosymbiosis. We are working to establish a dependency between free living cells, as a groundwork for a later endosymbiotic relationship. Natural endosymbiotic relationships have been found between fungi and bacteria in mycorrhiza strains (Bianciotti 2000), and we will be working with two cells from these two phylogenetic kingdoms in our project; a tryptophan auxotrophic yeast AM94 and E. coli.

Final Design

Background: Synthetic yeast media, suitable for growth of tryptophan auxotroph yeast, contains 76mg tryptophan pr. liter (Sigma-Aldrich, 2017). An accumulation of 1.7g tryptophan pr. liter was achieved by Gu et al. (2012) with a modified E.coli strain, which is sufficient for yeast growth. The production of tryptophan is regulated by negative feedback mechanisms that inhibits tryptophan synthesis in the presence of tryptophan or related amino acids.

Our goal is to produce and export enough tryptophan from E.coli to complement growth of an auxotroph yeast strain, grown in media without tryptophan. Additionally, we are interested in the number of endosymbionts necessary per host. This is included in our modelling.

Circuits and biobricks: In our circuit, we are overexpressing the three genes AroG, TrpE and YddG, which will also become our biobricks. We have made our selection based on the papers by Gu et al. (2012) and Wang et al. (2013).

TrpE belongs to the tryptophan operon and has been overexpressed frequently in L-tryptophan producing E. coli strains.
AroG is the first enzyme of the shikimate pathway, thereby determining the carbon flow towards tryptophan synthesis.


Both AroG and TrpE (Figure 1) are regulated by the concentration of the amino acids produced. This feedback signalling reduces the tryptophan concentration that we can achieve with WT E.coli aroG and trpE genes, as simply overexpressing them would lead to inhibition due to increased production.

We have made use of known mutant feedback resistant alleles for trpE and aroG to overcome this regulation (Gu et al., 2012). In the proteins TrpE, a mutation in a methionine to threonine at position 293 is required, and for AroG, the proline at position 150 is changed to leucine.

By making these point mutations, the feedback inhibition should be released, and overexpression would lead to elevated tryptophan production. We submitted the feedback resistant alleles as biobricks:

The last gene, yddG is an aromatic amino acid exporter and is responsible for the secretion of both tryptophan, tyrosine and phenylalanine.

Gu et al. (2012) have shown that the over-expression of YddG in E.coli increases the accumulation of tryptophan in the growth medium. This is likely due to the decrease in intracellular concentration, thus bypassing the feedback sensitive regulatory steps in tryptophan biosynthesis. We have designed a codon-optimised version of yddG that we have submittd as Biobrick BBa_K2455004.

Constructs with each gene, or two of the genes together, will be evaluated in order to examine both the combined and isolated effects of the genes.





Figure 1 AroG and TrpE location in aromatic amino acid biosynthesis: AroG initiates the shikimate pathway, and is inhibited by Phenylalanine. TrpE is the first protein in the trp operon and inhibited by tryptophan. The red crosses indicate feedback inhibition removed by the point mutations.

Experiments

Overview

Amplification of genes:
  • Synthetically produce a codon-optimised version of yddG
  • Amplify trpE and aroG with point mutations
  • Multi-gene constructs inserted in vector

Serial growth of E. coli and yeast

  • Identify a minimal media supporting both E. coli and yeast growth
  • Analyse auxotrophic yeast growth in the minimal media both with and without tryptophan added
  • Grow auxotrophic yeast in media only containing tryptophan produced by E.coli

Gene expression and tryptophan production

  • Western blotting to check expression of his-tagged proteins
  • HPLC-MS measurements of tryptophan production

Verifications

We have used gel electrophoresis in the majority of our experiments and sub-projects to continually monitor the progress.

All transformations in interdependency and protein import were done with USER cloningand the cells were grown ON on LB agar with the appropriate selection (Ampicillin or Chloramphenicol depending on the resistance marker). Colony PCRs were performed to pick colonies with the correct inserts for inoculation in liquid culture.

Subsequently, plasmids were cured from the cultures and PCR amplification and/or restriction digestion were used to check for correct insertion. Cells with appropriately sized inserts were sent to sequencing for sequence validation.

Biobrick creation

We amplified our biobricks with primers carrying the biobrick prefixes and suffixes as overhangs, and purified them with gel extraction. Subsequently, we used the standard iGEM protocol for its insertion into the pSB1C3 submission vector.

All biobricks were sequenced in the expression vector, and aroG, trpE, CPP and CPP-YFP were also sequenced following their insertion into the submission vector.

Vector design

A modified version of the pET102 vector was used for expression of all genes in this sub-project. See protein import for details on design and creation of the vector.

Codon optimization and synthetic yddG

Following problems with amplifying yddG from the genomic DNA, we decided to order a synthetically made version, and codon optimized it in the process.

Point mutations for feedback resistance in trpE and aroG

We amplified the aroG and trpE genes using genomic DNA from E.coli strain MG1655. The amplification was done using two sets of primers per gene, with overhangs allowing for insertion of a point mutation in each gene and for cloning with USER assembly.

The mutations were designed in accordance with previous work by Gu et al 2012. In TrpE, position 293 is changed from methionine to threonine, and for AroG position 150 is changed from proline to leucine.





Figure 2 Point mutation in trpE, and insertion in vector with USER assembly. To perform the point mutation, we designed two sets of primers for each gene. The outer primers are the same as used for amplification from the genomic DNA. The central primers have overhangs containing the point mutations. This way, the genes are split in two, and the two parts are combined when inserting in the USER cassette in the expression vector - and now containing a point mutation in the middle.


Design process



In our design process, we have considered a wide range of possible gene combinations. Genes that when over-expressed would have the greatest impact were chosen. This is due to the time constraints set and simplicity. Initially, we considered simply overexpressing the tryptophane operon, but quickly realised this would be highly downregulated due to negative feedback regulation.

We decided that an exporter would be beneficial by reducing the intracellular Trp concentration, which would release the feedback regulation. We also thought of deleting endogenous trpR, but making such a deletion would make our project overly complicated due to the difficulty of making such a deletion is E.coli.

Find Incell here: